Does Krill Oil Triglycerides Randomized Trial work?

Updated July 2026

Quick Answer

Krill Oil Triglycerides Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: BACKGROUND: Hypertriglyceridemia is a modifiable risk factor for cardiovascular disease, and while omega-3 fatty acids (omega-3 FAs) are known to lower triglyceride (TG) concentrations, their effectiveness is influenced by formulation and bioavailability.

Key Takeaways

  • 01BACKGROUND: Hypertriglyceridemia is a modifiable risk factor for cardiovascular disease, and while omega-3 fatty acids (omega-3 FAs) are known to lower triglyceride (TG) concentrations, their effectiveness is influenced by formulation and bioavailability. [Urina-Triana M (2026)]
  • 02Phospholipid-bound (PL) omega-3 FAs—such as those found in krill oil—demonstrate superior intestinal absorption and membrane integration compared with TG- and ethyl ester omega-3 FAs based forms. [Urina-Triana M (2026)]
  • 03Mean TG levels decreased slightly in the PL group (-9.1 mg/dL) and increased in the standard group (+ 15.2 mg/dL), with no statistically significant difference between-groups (p = 0.416). [Urina-Triana M (2026)]
  • 041 2 1 2 3 4 The age-related loss of muscle mass and strength, known as sarcopenia, is associated with reduced quality of life, greater risk of falls, and increased healthcare costs, estimated at £2.5 billion annually in the UK [,]. [Hayman Oliver (2026)]
The current Migaku evidence database contains 2 reusable source documents for Krill Oil Triglycerides Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - BACKGROUND: Hypertriglyceridemia is a modifiable risk factor for cardiovascular disease, and while omega-3 fatty acids (omega-3 FAs) are known to lower triglyceride (TG) concentrations, their effectiveness is influenced by formulation and bioavailability. [Urina-Triana M (2026); evidence level 2] - Phospholipid-bound (PL) omega-3 FAs—such as those found in krill oil—demonstrate superior intestinal absorption and membrane integration compared with TG- and ethyl ester omega-3 FAs based forms. [Urina-Triana M (2026); evidence level 2] - Mean TG levels decreased slightly in the PL group (-9.1 mg/dL) and increased in the standard group (+ 15.2 mg/dL), with no statistically significant difference between-groups (p = 0.416). [Urina-Triana M (2026); evidence level 2] - 1 2 1 2 3 4 The age-related loss of muscle mass and strength, known as sarcopenia, is associated with reduced quality of life, greater risk of falls, and increased healthcare costs, estimated at £2.5 billion annually in the UK [,]. [Hayman Oliver (2026); evidence level 2] - 5 6 7 8 9 10 11 Building on epidemiological [,], cell culture, and animal data [,], human research has demonstrated that 8 weeks of long-chain n-3 polyunsaturated fatty acid (LCn-3 PUFA) supplementation (fish oil, 4 g/day) increased muscle protein synthesis (MPS) during a hyperaminoacidaemic-hyperinsulinaemic clamp in older adults []. [Hayman Oliver (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Efficacy of phospholipid-bound omega-3 versus standard omega-3 in patients with hypertriglyceridemia: a randomized clinical trial.
  2. Do the effects of krill oil supplementation on skeletal muscle function and size in older adults differ by sex, age or BMI: A secondary analysis of a randomised controlled trial